Speaker Profile
M.D., CEO and Co-Founder, Inmedix
Biography
Andrew Holman is a clinical rheumatologist who discovered and published the role of dopamine agonists (Parkinson's disease medications) as a leading treatment for fibromyalgia (FM). This work, combined with the immunology training of rheumatology, led to exploration of how stress impacts autoimmune disease onset, activity, treatment response and potential remission. The concept is called immuno-autonomics and it is revolutionizing how doctors address stress biology, first in autoimmune disease, and next, in other diseases adversely impacted by stress.
Talk
Clinical & Research Tools Showcase:
Invivoscribe, Inc.
CloudHRV from Seattle-based Inmedix is FDA-cleared, reimbursed, 5-min, next-generation heart rate variability (HRV) in the clinic on a high-fidelity ECG platform. It is first and only to bring discrete indices of sympathetic (fight-or-flight) and parasympathetic (rest/restorative) state to the clinic as a missing vital sign.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
